Scielo RSS <![CDATA[Brazilian Journal of Infectious Diseases]]> vol. 11 num. lang. en <![CDATA[SciELO Logo]]> <![CDATA[<B>Consensus of the Brazilian Society of Infectious Diseases on the management and treatment of hepatitis C</B>]]> <![CDATA[<B>Epidemiological aspects of hepatitis C in Brazil</B>]]> <![CDATA[<B>Sexual transmission of HCV</B>]]> <![CDATA[<B>Hepatitis C virus perinatal transmission</B>]]> <![CDATA[<B>Hepatitis C</B>: <B>virological aspects and practical implications</B>]]> <![CDATA[<B>Pathogenesis of hepatitis C</B>: <B>HCV consensus 2007</B>]]> <![CDATA[<B>Antifibrotic therapy in chronic hepatitis C</B>]]> <![CDATA[<B>Laboratory testing for hepatitis C</B>]]> <![CDATA[<B>Hepatitis C</B>: <B>genotyping</B>]]> <![CDATA[<B>Chronic hepatitis C</B>: <B>pathological anatomy</B>]]> <![CDATA[<B>Co-infection with hepatitis B virus and hepatitis C virus</B>]]> <![CDATA[<B>Co-infection with hepatitis C virus and human T lymphocyte virus</B>]]> <![CDATA[<B>Basic guidelines for the treatment of HIV/HVC co-infection</B>]]> <![CDATA[<B>Basic aspects of the treatment for hepatitis C</B>: <B>mechanisms of action of interferon alpha and ribavirin and the bases of individualization</B>]]> <![CDATA[<B>Treatment of chronic hepatitis C in treatment-naïve patients</B>]]> <![CDATA[<B>Retreatment of hepatitis C patients who previously experienced treatment failure</B>]]> <![CDATA[<B>Maintenance treatment for the modulation of liver fibrosis</B>]]> <![CDATA[<B>Treatment of patients infected with hepatitis C virus and presenting extrahepatic manifestations</B>]]> <![CDATA[<B>Hepatitis C treatment before and after liver transplant</B>]]> <![CDATA[<B>Adverse event management</B>]]> <![CDATA[<B>Treatment options in the management of thrombocytopenia in patients infected with HCV</B>]]> <![CDATA[<B>Therapeutic perspectives for hepatitis C</B>]]>